At the core of Richards-Kortum’s acclaim lies her development of groundbreaking low-cost medical technologies that address critical global health challenges—from cervical cancer diagnostics to neonatal care innovations. Her approach transcends mere invention; it embodies a comprehensive systems perspective that integrates new medical technologies with the infrastructure, training, and sustainable practices necessary to ensure their successful adoption in diverse, real-world settings. By optimizing the entire ecosystem in which medical tools operate, her lab has catalyzed transformative advancements in disease detection and treatment, particularly for conditions such as cancer, infectious diseases, and sickle-cell anemia.

Richards-Kortum’s leadership extends to the Rice360 Institute for Global Health Technologies, which she co-directs. This multidisciplinary initiative unites engineers, clinicians, and students in a collaborative effort to design affordable, efficacious health solutions that respond to pressing medical needs. Through this platform, the institute has been pivotal in the establishment of NEST360, an international coalition dedicated to eliminating preventable newborn mortality in sub-Saharan Africa. By ensuring that life-saving technologies are coupled with trained healthcare workers, dependable supply chains, and data-enhanced management tools, NEST360’s model addresses systemic issues that often stymie health interventions in resource-poor contexts.

One of the principal challenges in global health technology deployment is ensuring sustainability beyond initial implementation. Richards-Kortum’s mission recognizes that medical innovation must be complemented by real-time, context-aware training programs that empower local health professionals. Her initiatives emphasize developing modular and scalable training paradigms that adapt to local health infrastructure, enabling seamless integration of bespoke technologies into existing medical workflows. This methodology critically enhances technology acceptance and impact, ensuring larger-scale, long-term improvements in health outcomes.

Technologically, Richards-Kortum’s laboratory has been at the forefront of advancing cost-effective optical imaging and diagnostic tools. These devices leverage principles of biomedical optics, including fluorescence imaging, spectroscopy, and advanced photonics, enabling early disease detection that is otherwise inaccessible in low-resource environments. For instance, her innovations in cervical cancer diagnostics utilize high-resolution, portable imaging systems capable of identifying precancerous lesions with high accuracy, circumventing the need for more complex and expensive laboratory infrastructure.

The translational impact of her research is exemplified in projects like the Center for Innovation and Translation of Point-of-Care Technologies for Expanded Cancer Care Access. Supported by the National Institutes of Health, this center focuses on the rapid development and clinical validation of affordable diagnostic instruments engineered to facilitate early cancer detection. By integrating microfluidic systems, machine learning algorithms for image analysis, and real-time data transmission capabilities, these devices are poised to revolutionize cancer care accessibility in settings lacking specialized pathology services.

In parallel, Richards-Kortum spearheads AccessPath, an ambitious initiative funded by the Advanced Research Projects Agency for Health (ARPA-H). AccessPath aims to democratize high-fidelity digital pathology by providing affordable, real-time analysis of tumor margins during surgery. This innovation reduces the frequency of repeat operations—a significant clinical and economic burden—by enabling immediate surgical decision-making with unprecedented precision. The integration of this technology into community and resource-limited hospitals represents a paradigm shift in oncologic surgery, potentially improving survival rates and quality of life.

The significance of Richards-Kortum’s achievements is echoed by leaders across academia and industry. Rice University President Reginald DesRoches highlights her embodiment of the university’s ethos—a blend of bold innovation and compassionate application. The broad influence of her work has inspired a generation of engineers and health professionals, compelling them to view engineering not merely as a technical discipline but as a powerful instrument for societal change. Her interdisciplinary approach fosters a culture where emerging technologies are continually aligned with ethical imperatives and real-world exigencies.

Over the course of her career, Richards-Kortum has authored an extensive body of scholarly work, including over 300 peer-reviewed papers and a globally utilized textbook on biomedical engineering for global health. These contributions reflect her dedication to education and the dissemination of knowledge crucial for cultivating the next generation of scientists and engineers. Moreover, her portfolio of over 40 patents underscores a prolific inventive capacity focused on addressing unmet clinical needs through novel technological solutions.

The recognition of Richards-Kortum extends beyond NAM election; she is also an esteemed fellow of the National Academy of Engineering, the National Academy of Sciences, the American Academy of Arts and Sciences, and the American Philosophical Society. Her accolades include a MacArthur Fellowship and recognition by Fortune magazine as one of the “World’s 50 Greatest Leaders.” Her influence further spans diplomatic and advisory roles, including serving as a U.S. Science Envoy for Health Security, testifying to her status as a global health ambassador.

Those closest to her work emphasize Richards-Kortum’s unique ability to integrate expertise across disciplinary boundaries and geographical borders. Amy Dittmar, Howard R. Hughes Provost and Executive VP for Academic Affairs at Rice, underscores Richards-Kortum’s role in transforming educational paradigms by seamlessly bridging engineering, medicine, and science education. This fusion enhances not only technological innovation but also the training environments that prepare students to address complex global health challenges with creativity and rigor.

Richards-Kortum’s election as a University Professor—a prestigious designation that is Rice’s highest academic rank—affirms her exceptional standing within the academic community. She joins a small cadre of Rice faculty elected to the National Academy of Medicine and is notably only the second faculty member from the George R. Brown School of Engineering and Computing to gain membership in all three national academies. This rare distinction underscores the caliber and interdisciplinary impact of her research contributions.

The leadership of the George R. Brown School of Engineering and Computing, including Dean Luay Nakhleh, praises Richards-Kortum for setting a high standard of engineering for social good. Her innovations are characterized by their practicality, scalability, and enduring partnerships that ensure technologies not only survive but thrive within complex healthcare ecosystems. Her work continues to position Rice University as a leading institution driving cutting-edge, socially impactful bioengineering research.

In 2025, the National Academy of Medicine welcomed 90 regular members and 10 international members, reflecting the institution’s ongoing commitment to expanding its pool of experts who provide objective analysis and policy guidance on critical health science challenges. Established in 1970 and operating under the broader umbrella of the National Academies of Sciences, Engineering, and Medicine, NAM serves as a cornerstone for scientific advice and leadership in matters affecting medicine and public health.

Richards-Kortum’s election to NAM symbolizes a broader institutional momentum at Rice toward integrating discovery and delivery frameworks that enhance healthcare outcomes. Through sustained, strategic partnerships within the Texas Medical Center and international collaborators, she exemplifies how meticulous research and thoughtful implementation can coalesce into durable improvements in global health. Her work embodies a vision where engineering transcends laboratory confines, emerging as a transformative force improving lives globally through innovation, education, and unwavering commitment to equity.

Subject of Research:
Biomedical engineering innovations for global health, specifically low-cost diagnostic and therapeutic technologies for cancer, neonatal, and infectious diseases.

Article Title:
Rebecca Richards-Kortum Elected to National Academy of Medicine for Pioneering Global Health Technologies

News Publication Date:
October 20, 2025

Web References:
https://mediasvc.eurekalert.org/Api/v1/Multimedia/cb796be0-81ea-4702-ad54-08a62b233370/Rendition/low-res/Content/Public

Image Credits:
Rice University

Keywords:
Health and medicine, Biomedical engineering, Health care, Human health, Medical technology, Clinical medicine, Clinical imaging, Medical diagnosis, Medical treatments, Translational medicine, Preventive medicine, Diseases and disorders, Engineering education

The carbon impact of anesthetic gases is particularly concerning. While they are effective in providing necessary sedation during surgeries, these gases contribute significantly to global warming. Desflurane, a commonly used inhaled anesthetic, is a prime example, having been documented to be almost 8,000 times more effective than carbon dioxide in terms of its greenhouse gas impact over five years. Each kilogram of desflurane used can result in CO2 equivalent emissions comparable to driving a vehicle for nearly 7,850 kilometers, highlighting the urgent need for alternatives in clinical practices.

Recognizing the severity of the situation, Charité undertook substantial reform in 2018, focusing on educating anesthesiologists about the environmental consequences of their choices. Dr. Susanne Koch, a pivotal figure in this initiative, emphasizes that most practitioners were not aware of the lasting climate effects caused by inhaled anesthetics. Consequently, Charité instituted regular educational programs and continuing professional education activities aimed at elevating awareness of sustainable practices among anesthesiologists.

The response from the anesthesiology departments at Charité was swift and decisive. New guidelines were established to prioritize climate-friendly alternatives, effectively rendering the use of desflurane obsolete as of late 2023. The hospital transitioned towards local anesthesia and intravenous anesthetics like propofol, which have been shown to have a significantly lower environmental impact. These methods not only minimize the carbon emissions associated with anesthesia but also facilitate better outcomes for patients. Studies indicate that propofol-treated patients often exhibit reduced nausea and a calmer awakening compared to those who undergo anesthesia with desflurane.

The financial implications of this shift are equally noteworthy. Charité’s reduced reliance on desflurane has led to significant cost savings, with expenditures for anesthetic agents declining by nearly 50 percent between 2015 and 2023. The annual reduction in carbon emissions from over 7,500 metric tons to just 1,454 metric tons demonstrates not only a commitment to sustainability but also reflects the institution’s strategic financial management. This represents a saving of approximately 6,000 metric tons of CO2 emissions a year—an amount comparable to the annual emissions of around 300 German households.

The real impact of Charité’s transformation stems from the management decisions that underpinned their sustainability initiatives. In research conducted by Dr. Koch and her team, they discovered that the most immediate and transformative changes arose from structural adjustments mandated by hospital leadership. Implementing centralized rules for anesthesiology practices ensured that every professional was aligned with the institution’s sustainability goals, pointing to the critical role of organizational governance in achieving long-term environmental aims.

The approach taken by Charité demonstrates the importance of education within the medical field, particularly as it intersects with environmental consciousness. By holding informational events and sharing knowledge internally and at conferences, Charité has fostered an ongoing dialogue about the implications of anesthetic gases. This exchange of information is proving invaluable in developing best practices that prioritize human health and environmental integrity concurrently.

Moreover, the hospital’s sustainability efforts extend beyond just anesthetic gases; Charité embraces the United Nations Sustainable Development Goals in its broader operational strategies. Initiatives such as replacing conventional lighting with energy-efficient LEDs and adopting sustainable materials for staff uniforms indicate an extensive commitment to reducing its overall carbon footprint. These improvements have resulted in a decrease of CO2 emissions from 126,600 metric tons in 2016 to 104,320 metric tons in 2023, solidifying Charité’s role as a model for sustainability in healthcare.

However, the sustainability journey for healthcare institutions does not conclude with the elimination of harmful gases. Ongoing research and adaptation will be necessary to keep pace with the evolving landscape of medical practices and environmental standards. By continuously monitoring and refining their anesthetic protocols, Charité aims to advance sustainability further, ensuring that their practices set a precedent for others within the healthcare sector.

The outcomes at Charité inspire a wave of enthusiasm among medical professionals who recognize that sustainable practices can be seamlessly integrated into daily operations without compromising patient care. As evidenced by the positive feedback regarding patient experiences under the new anesthetic protocols, educators and practitioners alike can see that sustainable choices in medicine yield tangible benefits.

This progressive viewpoint aligns with the general shift in societal awareness surrounding climate change and emphasizes the necessity for healthcare providers to act as stewards of the environment. In embracing this paradigm shift, institutions can not only fulfill their ethical obligations to care for patients but also champion the health of the planet.

It is essential for medical institutions worldwide to take heed of Charité’s example, embracing education, management, and sustainable anesthetic practices to mitigate their environmental impact. With the healthcare sector being a significant contributor to global greenhouse gas emissions, the responsibility lies with these entities to lead the charge toward sustainable solutions. Charité demonstrates that change is possible when a collective commitment underlines the values of innovation, education, and environmental stewardship.

As the quest for reducing carbon emissions faces ongoing challenges across numerous sectors, healthcare providers have the unique opportunity to adopt strategies that serve both immediate patient needs and longer-term sustainability objectives. By investing in education and embracing systemic changes, institutions can pave the way for future advancements in environmentally conscious medical practice, setting a global benchmark that transcends national boundaries.

This narrative of transformation at Charité resonates widely within the scientific community, inspiring other healthcare organizations to prioritize sustainability as a core value. The healthcare sector can illuminate a pathway toward reducing its carbon footprint and contribute significantly to global efforts in combating climate change, all while providing high-quality patient care and advancing medical science.

Subject of Research: Carbon emissions reduction in anesthesia practices
Article Title: The Power of Education to Reduce the Carbon Footprint of Volatile Anesthetics in Clinical Practice
News Publication Date: (Not provided)
Web References: (Not provided)
References: Schwiethal A et al. The Power of Education to Reduce the Carbon Footprint of Volatile Anesthetics in Clinical Practice. Anesth Analg. 2025 Feb 25. doi: 10.1213/ANE.0000000000007375
Image Credits: © Charité | Artur Krutsch
Keywords: Anesthesia, Carbon emissions, Sustainability, Environmental impact, Desflurane, Propofol, Healthcare, Education, Climate change, CO2 emissions, Anesthesiology, Charité.